DK1001783T3 - Behandling af diabetes med thiazolidindion, insulinsekretagog og biguanid - Google Patents

Behandling af diabetes med thiazolidindion, insulinsekretagog og biguanid

Info

Publication number
DK1001783T3
DK1001783T3 DK98935127T DK98935127T DK1001783T3 DK 1001783 T3 DK1001783 T3 DK 1001783T3 DK 98935127 T DK98935127 T DK 98935127T DK 98935127 T DK98935127 T DK 98935127T DK 1001783 T3 DK1001783 T3 DK 1001783T3
Authority
DK
Denmark
Prior art keywords
thiazolidinedione
biguanide
diabetes
treatment
insulin secretagogue
Prior art date
Application number
DK98935127T
Other languages
Danish (da)
English (en)
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK1001783T3 publication Critical patent/DK1001783T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DK98935127T 1997-07-18 1998-07-16 Behandling af diabetes med thiazolidindion, insulinsekretagog og biguanid DK1001783T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715295A GB9715295D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
DK1001783T3 true DK1001783T3 (da) 2006-02-06

Family

ID=10816167

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98935127T DK1001783T3 (da) 1997-07-18 1998-07-16 Behandling af diabetes med thiazolidindion, insulinsekretagog og biguanid

Country Status (39)

Country Link
EP (1) EP1001783B1 (cg-RX-API-DMAC7.html)
JP (2) JP2001510159A (cg-RX-API-DMAC7.html)
KR (1) KR100671918B1 (cg-RX-API-DMAC7.html)
CN (1) CN1264303A (cg-RX-API-DMAC7.html)
AP (1) AP1352A (cg-RX-API-DMAC7.html)
AR (1) AR016349A1 (cg-RX-API-DMAC7.html)
AT (1) ATE305790T1 (cg-RX-API-DMAC7.html)
AU (1) AU8448898A (cg-RX-API-DMAC7.html)
BG (1) BG64785B1 (cg-RX-API-DMAC7.html)
BR (1) BR9810445A (cg-RX-API-DMAC7.html)
CA (1) CA2296653C (cg-RX-API-DMAC7.html)
CO (1) CO4940420A1 (cg-RX-API-DMAC7.html)
CY (1) CY1105254T1 (cg-RX-API-DMAC7.html)
DE (1) DE69831808T2 (cg-RX-API-DMAC7.html)
DK (1) DK1001783T3 (cg-RX-API-DMAC7.html)
DZ (1) DZ2562A1 (cg-RX-API-DMAC7.html)
EA (1) EA003021B1 (cg-RX-API-DMAC7.html)
ES (1) ES2251093T3 (cg-RX-API-DMAC7.html)
GB (1) GB9715295D0 (cg-RX-API-DMAC7.html)
HU (1) HUP0003629A3 (cg-RX-API-DMAC7.html)
ID (1) ID24211A (cg-RX-API-DMAC7.html)
IL (1) IL134046A0 (cg-RX-API-DMAC7.html)
IN (1) IN189275B (cg-RX-API-DMAC7.html)
MA (1) MA24607A1 (cg-RX-API-DMAC7.html)
MY (1) MY155219A (cg-RX-API-DMAC7.html)
NO (1) NO325727B1 (cg-RX-API-DMAC7.html)
NZ (2) NZ501164A (cg-RX-API-DMAC7.html)
OA (1) OA11279A (cg-RX-API-DMAC7.html)
PE (1) PE99599A1 (cg-RX-API-DMAC7.html)
PL (2) PL198017B1 (cg-RX-API-DMAC7.html)
SA (1) SA98190468B1 (cg-RX-API-DMAC7.html)
SI (1) SI1001783T1 (cg-RX-API-DMAC7.html)
SK (1) SK285484B6 (cg-RX-API-DMAC7.html)
TR (1) TR200000134T2 (cg-RX-API-DMAC7.html)
TW (1) TW505516B (cg-RX-API-DMAC7.html)
UA (1) UA70303C2 (cg-RX-API-DMAC7.html)
UY (1) UY25102A1 (cg-RX-API-DMAC7.html)
WO (1) WO1999003477A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA986363B (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
CZ20011629A3 (cs) * 1998-11-12 2001-12-12 Smithkline Beecham Plc Farmaceutický prostředek pro upravené uvolňování senzitizéru inzulínu a jiných antidiabetických přípravků
SE9902918D0 (sv) * 1999-08-13 1999-08-13 Pharmacia & Upjohn Ab Methods for identification of compounds stimulating insulin secretion
AU1403501A (en) * 1999-11-16 2001-05-30 Smithkline Beecham Plc Novel composition and use
MY125516A (en) * 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
FR2812547B1 (fr) * 2000-08-04 2002-10-31 Lipha Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
PL362687A1 (en) 2001-01-12 2004-11-02 Sun Pharmaceutical Industries Limited Spaced drug delivery system
ITFI20010126A1 (it) * 2001-07-09 2003-01-09 Molteni & C Composizioni farmaceutiche per uso orale,contenenti,in combinazione,metformina e gliclazide
CA2453775A1 (en) * 2001-07-10 2003-01-23 Kos Life Sciences, Inc. Core formulation comprising pioglitazone hydrochloride and a biguanide
AU2002356419A1 (en) 2002-06-17 2003-12-31 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
EP2604266A1 (en) * 2002-09-20 2013-06-19 Andrx Labs Llc Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
UA80991C2 (en) 2002-10-07 2007-11-26 Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
KR100952090B1 (ko) 2003-10-31 2010-04-13 다케다 야쿠힌 고교 가부시키가이샤 인슐린 감작제, 인슐린 분비촉진제 및 폴리옥시에틸렌소르비탄 지방산 에스테르를 함유하는 고체 제제
MXPA05010977A (es) * 2005-10-12 2007-04-11 Abdala Leopoldo Espinosa Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus.
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제
CN101417130B (zh) * 2007-10-22 2010-10-06 鲁南制药集团股份有限公司 一种治疗ⅱ型糖尿病及其并发症的药物组合物
JP7005050B2 (ja) * 2017-10-20 2022-01-21 ノブメタファーマ カンパニー リミテッド 亜鉛塩、シクロ－ヒスプロおよび抗糖尿薬物を有効成分として含有する糖尿病の予防または治療用薬学的組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
FI904414A7 (fi) * 1988-03-08 1990-09-07 Pfizer Tiatsolidiinidioni-hypoglykeemisesti vaikuttavat aineet
MX15171A (es) * 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
WO1993003724A1 (en) * 1991-08-26 1993-03-04 The Upjohn Company Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
DE69837089T2 (de) * 1997-06-18 2007-06-21 Smithkline Beecham P.L.C., Brentford Behandlung der diabetes mit thiazolidindion und sulfonylharnstoff

Also Published As

Publication number Publication date
DE69831808D1 (de) 2006-02-16
PE99599A1 (es) 1999-12-18
EP1001783A1 (en) 2000-05-24
WO1999003477A1 (en) 1999-01-28
NZ501164A (en) 2001-06-29
ZA986363B (en) 2000-01-17
AR016349A1 (es) 2001-07-04
EA003021B1 (ru) 2002-12-26
HK1028550A1 (en) 2001-02-23
HUP0003629A2 (hu) 2001-07-30
PL197844B1 (pl) 2008-05-30
SI1001783T1 (sl) 2006-02-28
AP1352A (en) 2004-12-24
DE69831808T2 (de) 2006-07-06
ID24211A (id) 2000-07-13
NO20000228D0 (no) 2000-01-17
PL338126A1 (en) 2000-09-25
BG64785B1 (bg) 2006-04-28
CY1105254T1 (el) 2010-03-03
UY25102A1 (es) 2000-12-29
GB9715295D0 (en) 1997-09-24
UA70303C2 (uk) 2004-10-15
SA98190468B1 (ar) 2007-01-20
SK592000A3 (en) 2000-09-12
ATE305790T1 (de) 2005-10-15
BG104135A (en) 2000-10-31
TW505516B (en) 2002-10-11
EA200000139A1 (ru) 2000-06-26
JP2005213273A (ja) 2005-08-11
OA11279A (en) 2003-07-31
NZ511608A (en) 2002-12-20
MA24607A1 (fr) 1999-04-01
KR20010021947A (ko) 2001-03-15
JP2001510159A (ja) 2001-07-31
AU8448898A (en) 1999-02-10
SK285484B6 (sk) 2007-02-01
AP2000001733A0 (en) 2000-03-31
ES2251093T3 (es) 2006-04-16
MY155219A (en) 2015-09-30
CN1264303A (zh) 2000-08-23
BR9810445A (pt) 2000-09-05
CA2296653C (en) 2007-10-02
NO325727B1 (no) 2008-07-07
CO4940420A1 (es) 2000-07-24
TR200000134T2 (tr) 2000-09-21
DZ2562A1 (fr) 2003-02-15
CA2296653A1 (en) 1999-01-28
PL198017B1 (pl) 2008-05-30
IL134046A0 (en) 2001-04-30
IN189275B (cg-RX-API-DMAC7.html) 2003-01-25
KR100671918B1 (ko) 2007-01-22
EP1001783B1 (en) 2005-10-05
NO20000228L (no) 2000-01-17
HUP0003629A3 (en) 2003-04-28

Similar Documents

Publication Publication Date Title
DK0996444T3 (da) Behandling af diabetes med thiazolidindion og metformin
DK1001783T3 (da) Behandling af diabetes med thiazolidindion, insulinsekretagog og biguanid
DK1183020T3 (da) (3-trihalogenmethylphenoxy)(4-halogenphenyl) til behandling af insulinresistens og type 2-diabetes
DK1228067T3 (da) 5-leddede heterocykliske forbindelser med hypoglykæmisk og hypolipidæmisk virkning
DK1174135T3 (da) Farmaceutisk sammensætning omfattende pioglitazon og glimepirid til anvendelse i behandling af diabetes
PT1128834E (pt) Combinacoes contra a diabetes contendo gliburida, troglitazona (e uma biguanida)
PT1017408E (pt) Utilizacao de tetra-hidrolipstatina no tratamento de diabetes de tipo ii
NO996265D0 (no) Behandling av diabetes med rosiglitazon og insulin
NO20035056D0 (no) Adenosinanaloger for behandling av insulinresistenssyndrom og diabetes
NO20000230D0 (no) Behandling av diabetes med tiazolidindion, insulin sekretagogue og <alfa>glukosidaseinhibitor
NO984578D0 (no) Piezoelektrisk resonator og komponent med samme
DK0998291T4 (da) Behandling af diabetes med thiazolidindion og sulphonylurinstof
NO996264L (no) Behandling av diabetes med tiazolidindion og sulfonylurea
NO996270D0 (no) Behandling av diabetes med tiazolidindion og <alfa>- glukosidaseinhibitor
HUP0002668A3 (en) Treatment of diabetes with thiazolidinedione and metformin
HK1028551A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucosidase inhibitor
HUP0002669A3 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
DK194191A (da) Tolerant system med en flerbrugerbehandlingsenhed og fremgangsmaade til styring af dette
DK1077957T3 (da) Oxyiminoalkansyrederivater med hypoglykæmisk og hypolipidæmisk aktivitet